Verification evidence is still being completed.
Pratia Poland
Warsaw, Poland
- Verified lead
- Łukasz Bęczkowski
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Operating Officer
- 2026 technical specialization
- Research Site Network Operations, Hybrid Trials, and Decentralized Clinical Execution
- Review cycle
- May 2026
- Full address
- Warsaw, Poland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Pratia leadership profile confirming Łukasz Bęczkowski as COO.
- Editorial note
- Pratia is published with the current public operating lead, Łukasz Bęczkowski, rather than inventing a separate Poland CEO that the company does not publicly disclose.
Research Site Network Operations, Hybrid Trials, and Decentralized Clinical Execution
GCP, EMA, FDA and GDPR operating framework, Hybrid and decentralized trial controls
Pratia is published with the current public operating lead, Łukasz Bęczkowski, rather than inventing a separate Poland CEO that the company does not publicly disclose.
Pratia Poland runs site network operations, hybrid trials, and decentralized trial delivery in Warsaw, Poland.
- Lead
- Łukasz Bęczkowski (verified ↗)
- Address
- Warsaw, Poland (source ↗)
- Compliance
- GCP, EMA, FDA and GDPR operating framework
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Multi-country site-network platform
- Capabilities
- Site Network Operations · Hybrid Trials · Decentralized Trial Delivery
- Founded
- 2016
- Headcount
- 501-1000
- Company page (open ↗)
Łukasz Bęczkowski
Chief Operating Officer
Official Pratia expansion release confirming the Warsaw operating node in Poland.
Open sourceMulti-country site-network platform
Warsaw, Poland. Research Site Network Operations, Hybrid Trials, and Decentralized Clinical Execution. Review completed on 14 Mar 2026.
EU and local clinical-trial oversight
GCP, EMA, FDA and GDPR operating framework, Hybrid and decentralized trial controls
Research Site Network Operations, Hybrid Trials, and Decentralized Clinical Execution
Pratia is published with the current public operating lead, Łukasz Bęczkowski, rather than inventing a separate Poland CEO that the company does not publicly disclose.
Pratia is published with the current public operating lead, Łukasz Bęczkowski, rather than inventing a separate Poland CEO that the company does not publicly disclose.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Pratia Poland located?
- Pratia Poland operates from Warsaw, Poland, Warsaw, Poland.
- Who runs Pratia Poland?
- Pratia Poland is led by Łukasz Bęczkowski, Chief Operating Officer. Verified 14 Mar 2026.
- What certifications does Pratia Poland hold?
- Pratia Poland is documented under GCP, EMA, FDA and GDPR operating framework.
- What does Pratia Poland do?
- Pratia Poland runs site network operations, hybrid trials, and decentralized trial delivery in Warsaw, Poland. Core capabilities: Site Network Operations, Hybrid Trials, Decentralized Trial Delivery, Investigator Access.
Related technical briefs
Briefs that name Warsaw as a covered market or city.
